24 hr desvenlafaxine succinate 50 mg extended release oral tablet
1 INDICATIONS AND USAGE Desvenlafaxine is indicated for the treatment of adults with major depressive disorder (MDD) [see Clinical Studies (14)] . Desvenlafaxine is a serotonin and norepinephrine reuptake inhibitor (SNRI) indicated for the treatment of adults with major depressive disorder (MDD) ( 1 ).
breckenridge pharmaceutical, inc
ROUND PINK L 349
L 349 ROUND PINK
Related Pills
24 hr desvenlafaxine succinate 50 mg extended release oral tablet
breckenridge pharmaceutical, inc
24 hr desvenlafaxine succinate 50 mg extended release oral tablet
breckenridge pharmaceutical, inc
DISCLAIMER:
"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."
"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."
"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."
PillSync may earn a commission via links on our site
16 HOW SUPPLIED/STORAGE AND HANDLING Desvenlafaxine Extended-Release Tablets are available as follows: 25 mg, tan colored, round, biconvex tablets, debossed with ‘L634’ on one side and plain on other side. NDC 51991-006-33, bottle of 30 tablets in unit-of-use package NDC 51991-006-90, bottle of 90 tablets in unit-of-use package NDC 51991-006-01, bottle of 100 tablets NDC 51991-006-10, bottle of 1,000 tablets NDC 51991-006-11, carton of 100 (10 x 10) unit-dose tablets NDC 51991-006-80, carton of 80 (10 x 8) unit-dose tablets 50 mg, light pink colored, round, biconvex tablets, debossed with ‘L349’ on one side and plain on other side. NDC 51991-311-14, bottle of 14 tablets in unit-of-use package NDC 51991-311-33, bottle of 30 tablets in unit-of-use package NDC 51991-311-90, bottle of 90 tablets in unit-of-use package NDC 51991-311-01, bottle of 100 tablets NDC 51991-311-10, bottle of 1,000 tablets NDC 51991-311-11, carton of 100 (10 x 10) unit-dose tablets NDC 51991-311-80, carton of 80 (10 x 8) unit-dose tablets 100 mg, dark brown to red colored, round, biconvex tablets, debossed with ‘L350’ on one side and plain on other side. NDC 51991-312-14, bottle of 14 tablets in unit-of-use package NDC 51991-312-33, bottle of 30 tablets in unit-of-use package NDC 51991-312-90, bottle of 90 tablets in unit-of-use package NDC 51991-312-01, bottle of 100 tablets NDC 51991-312-10, bottle of 1,000 tablets NDC 51991-312-11, carton of 100 (10 x 10) unit-dose tablets NDC 51991-312-80, carton of 80 (10 x 8) unit-dose tablets Store at 20° to 25°C (68° to 77°F); excursions permitted to 15° to 30°C (59° to 86°F). [See USP Controlled Room Temperature] Each tablet contains 38 mg, 76 mg or 152 mg of
DESVENLAFAXINE SUCCINATE equivalent to 25 mg, 50 mg or 100 mg of desvenlafaxine, respectively.
More pills like ROUND L 349